跳至主要内容
临床试验/ACTRN12613000236796
ACTRN12613000236796已完成不适用

In patients with mild to moderate ulcerative colitis, does faecal transplant induce clinical remission compared to placebo

Royal Adelaide Hospital0 个研究点目标入组 70 人开始时间: 2013年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • 1. Mild to moderate active ulcerative colitis (total Mayo score 2 to 10)
  • 2. Endoscopic subscore of 2 or greater (to ensure symptoms are due to UC (not post-inflammatory IBS)
  • 3. Adult patients (aged greater than 18 years)

排除标准

  • 1. Severe ulcerative colitis (Mayo score 11-12 or Truelove and Witts criteria)
  • 2. More than 25mg of prednisolone per day (or equivalent steroid)
  • 3. Previous colonic surgery
  • 4. Active gastrointestinal infection
  • 5.Pregnancy
  • 6. Anticoagulant therapy or duel antiplatelet therapy (i.e. aspirin and clopidogrel)
  • 7. Current use of antibiotics
  • 8. Anti-TNF therapy

研究者

相似试验

Faecal transplant for the treatment of active... | 临床试验